An international survey on genetics in clinical practice for interstitial lung disease.

M. Terwiel (Nieuwegein, Netherlands), R. Borie (Paris, France), B. Crestani (Paris, France), L. Galvin (Gentbrugge, Belgium), F. Bonella (Essen, Germany), A. Fabre (Dublin, Ireland), A. Froidure (Louvain, Belgium), M. Griese (München, Germany), J. Grutters (Nieuwegein, Netherlands), K. Johannson (Calgary, Canada), C. Kannengiesser (Paris, France), L. Kawano (Paris, France), M. Molina-Molina (Barcelona, Spain), A. Prasse (Hannover, Germany), E. Renzoni (London, United Kingdom), J. Van Der Smagt (Utrecht, Netherlands), V. Poletti (Forli, Italy), K. Antoniou (Heraklion, Greece), C. Van Moorsel (Nieuwegein, Netherlands)

Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Terwiel (Nieuwegein, Netherlands), R. Borie (Paris, France), B. Crestani (Paris, France), L. Galvin (Gentbrugge, Belgium), F. Bonella (Essen, Germany), A. Fabre (Dublin, Ireland), A. Froidure (Louvain, Belgium), M. Griese (München, Germany), J. Grutters (Nieuwegein, Netherlands), K. Johannson (Calgary, Canada), C. Kannengiesser (Paris, France), L. Kawano (Paris, France), M. Molina-Molina (Barcelona, Spain), A. Prasse (Hannover, Germany), E. Renzoni (London, United Kingdom), J. Van Der Smagt (Utrecht, Netherlands), V. Poletti (Forli, Italy), K. Antoniou (Heraklion, Greece), C. Van Moorsel (Nieuwegein, Netherlands). An international survey on genetics in clinical practice for interstitial lung disease.. 2339

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

A pragmatic clinical classification for interstitial lung disease
Source: Annual Congress 2012 - Reclassification of idiopathic interstitial pneumonias
Year: 2012


The significance of addind rheumatological assessment to the multidisciplinary team in the diagnosis of interstitial lung disease.
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Nationwide survey of physicians' attitude and approach to the clinical evaluation of interstitial lung disease in Singapore
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Interstitial lung disease in childhood. A clinical review
Source: Eur Respir J 2004; 24: Suppl. 48, 624s
Year: 2004

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study
Source: ERJ Open Res, 5 (2) 00209-2018; 10.1183/23120541.00209-2018
Year: 2019



Global characterisation of routine care interstitial lung disease diagnostic practice
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Challenges facing parents/caregivers of children with interstitial lung disease (chILD): international survey
Source: International Congress 2018 – Insights in primary ciliary dyskinesia, asthma and lung function testing
Year: 2018

Survey of COPD management among the primary care physicians in Korea – study for the development and dissemination of the COPD guidelines – clinical research center for chronic obstructive airway disease
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008


Collating data from major European population studies – The CADSET (Chronic airway disease early stratification) clinical research collaboration
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




A survey of children’s interstitial lung disease (ChILD) databases across the EU and an ability to identify pan-registry clinical trial cohorts
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019

Translating research into practice: how are guidelines implemented?
Source: Eur Respir J 2003; 21: 23S-29S
Year: 2003



How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians
Source: ERJ Open Res, 6 (1) 00286-2019; 10.1183/23120541.00286-2019
Year: 2020



Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases.
Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Year: 2020




Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis
Source: Eur Respir Rev 2012; 21: 48-56
Year: 2012



The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019


COPD management in Swedish clinical practice
Source: Annual Congress 2007 - Primary care management of COPD
Year: 2007


Clinical use of interstitial lung disease guidelines
Source: Eur Respir Mon; 2009: 46: 386–395
Year: 2009

Clinical presentation and spectrum of paediatric interstitial lung disease in Europe
Source: Annual Congress 2007 - Paediatric interstitial lung disease: an orphan coming of age
Year: 2007


Interstitial lung disease multi-disciplinary meeting: an English teaching hospital‘s experience
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007